BR112014004332A2 - device for generating an energy field for the treatment of cancer in body cavities and cavity-shaped parts - Google Patents

device for generating an energy field for the treatment of cancer in body cavities and cavity-shaped parts

Info

Publication number
BR112014004332A2
BR112014004332A2 BR112014004332A BR112014004332A BR112014004332A2 BR 112014004332 A2 BR112014004332 A2 BR 112014004332A2 BR 112014004332 A BR112014004332 A BR 112014004332A BR 112014004332 A BR112014004332 A BR 112014004332A BR 112014004332 A2 BR112014004332 A2 BR 112014004332A2
Authority
BR
Brazil
Prior art keywords
cancer
treatment
body cavity
generating
shaped parts
Prior art date
Application number
BR112014004332A
Other languages
Portuguese (pt)
Other versions
BR112014004332A8 (en
BR112014004332B1 (en
Inventor
P Adams Carolyn
B Mickenna Daniel
M Frantz Karl
A Huisjen Martin
E Susedik Michael
Original Assignee
Actium Biosystems Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actium Biosystems Llc filed Critical Actium Biosystems Llc
Priority claimed from PCT/US2012/051763 external-priority patent/WO2013032792A1/en
Publication of BR112014004332A2 publication Critical patent/BR112014004332A2/en
Publication of BR112014004332A8 publication Critical patent/BR112014004332A8/en
Publication of BR112014004332B1 publication Critical patent/BR112014004332B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N2/00—Magnetotherapy
    • A61N2/02—Magnetotherapy using magnetic fields produced by coils, including single turn loops or electromagnets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)
  • Magnetic Treatment Devices (AREA)

Abstract

resumo dispositivo para a geração de um campo energético para o tratamento de câncer em cavidades corporais e partes em formato de cavidade o dispositivo para o tratamento do câncer em cavidades corporais gera um campo magnético para uso combinado de "hipertermia de baixa temperatura" e radiação ionizante e/ou protocolo de tratamento quimioterápico do câncer. ao contrário de outros sistemas concorrentes, o dispositivo para o tratamento do câncer em cavidades corporais não mata ou extirpa diretamente as células cancerígenas com temperaturas elevadas, ao contrário, o dispositivo para o tratamento do câncer em cavidades corporais danifica o câncer e as células-tronco do câncer mantendo-as a uma temperatura nominal de 42º celsius por um determinado período de tempo por meio do aquecimento de nanopartículas que tenham sido infundidas na bexiga, utilizando o campo magnético gerado. 1/1device for generating an energy field for the treatment of body cavity cancer and cavity-shaped parts the device for the treatment of body cavity cancer generates a magnetic field for the combined use of "low temperature hyperthermia" and ionizing radiation and / or cancer chemotherapy treatment protocol. Unlike other competing systems, the device for treating body cavity cancer does not directly kill or excise cancer cells at elevated temperatures, but the device for treating body cavity cancer damages cancer and stem cells. cancer by maintaining them at a nominal temperature of 42 degrees Celsius for a period of time by heating nanoparticles that have been infused into the bladder using the generated magnetic field. 1/1

BR112014004332-9A 2011-08-26 2012-08-21 Device and method for raising the temperature of an iron oxide nanoparticle solution in a biological tissue cavity BR112014004332B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161527928P 2011-08-26 2011-08-26
US61/527,928 2011-08-26
PCT/US2012/051763 WO2013032792A1 (en) 2011-08-26 2012-08-21 Apparatus for the generation of an energy field for the treatment of cancer in body cavities and parts that are cavity-like

Publications (3)

Publication Number Publication Date
BR112014004332A2 true BR112014004332A2 (en) 2017-03-21
BR112014004332A8 BR112014004332A8 (en) 2017-10-03
BR112014004332B1 BR112014004332B1 (en) 2019-05-21

Family

ID=58343358

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014004332-9A BR112014004332B1 (en) 2011-08-26 2012-08-21 Device and method for raising the temperature of an iron oxide nanoparticle solution in a biological tissue cavity

Country Status (1)

Country Link
BR (1) BR112014004332B1 (en)

Also Published As

Publication number Publication date
BR112014004332A8 (en) 2017-10-03
BR112014004332B1 (en) 2019-05-21

Similar Documents

Publication Publication Date Title
ES2544967T3 (en) Formulation and method for the prevention and treatment of bone metastases or other bone diseases
HK1222310A1 (en) Surgical snare with ability to deliver electromagnetic energy and or thermal plasma into biological tissue
BR112014031874A2 (en) method for preparing high concentration stem cells
BR112012009039A2 (en) contraceptive methods and devices
AR092661A1 (en) REINFORCED KINASE INHIBITOR DURING TRANSFECTION (RET) AND A METHOD FOR IDENTIFYING A SENSITIVE PATIENT TO A COMPOSITE REPRESENTED BY FORMULA (1)
GB2531952A (en) SC-ß cells and compositions and methods for generating the same
TR201909582T4 (en) Pyrimido [4,5-b] indole derivatives and their use in the expression of hematopoietic stem cells.
UA118248C2 (en) Glucosylceramide synthase inhibitors
BR112015026297A2 (en) combination therapy consisting of a tor kinase inhibitor and a substituted 5-quinazolinone compound for cancer treatment
BR112015017490A2 (en) use of inorganic nanoparticles
BR112015023020A2 (en) combination of egfr t790m inhibitor and egfr inhibitor for the treatment of non-small cell lung cancer
CO6551693A2 (en) COMPOSITIONS TO TREAT NAUSEAS AND CENTRALLY MEDIUM VOMITING
BRPI0900105A2 (en) implantable drive restraint systems using temperature
BR112012031616A2 (en) crystalline form of benzylbenzene inhibitor sglt2
AR084567A1 (en) IMPLANT WITH CALCIUM IN ITS SURFACE AND METHODS OF MODIFICATION OF THE SURFACE OF AN IMPLANT TO PROVIDE SUCH CALCIUM SURFACE
BR112015022907A8 (en) crystalline forms of (s) -quinuclidin-3-yl (2- (2- (4-fluorophenyl) thiazol-4-yl) propan-2-yl) carbamate salt and its uses
BR112015027477A2 (en) Method for Treating a Swallowing Disorder
CL2016001510A1 (en) Stem cells derived from mammalian muscle
BR112012022243A2 (en) thioxantone-based autograph inhibitor therapies to treat cancer
MX2016003127A (en) Methods of using adipose tissue-derived cells in the modulation of pain and/or fibrosis.
AR113122A1 (en) METHOD TO IMPROVE THE STABILITY IN STORAGE AND BIOLOGICAL FITNESS OF FUNGAL SPORES
SG10201804952QA (en) Glucosylceramide synthase inhibitors
BR112015020667A2 (en) method of preparing glucosylceramide synthase inhibitors
ES2570386T3 (en) Procedure of biological fight against Pseusomonas
BR112018067967A2 (en) treatment of patients with homozygous familial hypercholesterolaemia by hypolipidemic therapy

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Ipc: A61N 2/02 (2006.01), A61B 6/02 (2006.01)

B65X Notification of requirement for priority examination of patent application
B65Y Grant of priority examination of the patent application (request complies with dec. 132/06 of 20061117)
B25C Requirement related to requested transfer of rights

Owner name: ACTIUM BIOSYSTEMS, LLC (US)

B25A Requested transfer of rights approved

Owner name: ENDOMAGNETICS LIMITED (GB)

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/08/2012, OBSERVADAS AS CONDICOES LEGAIS. (CO) 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/08/2012, OBSERVADAS AS CONDICOES LEGAIS